Aravive (ARAV)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	8.54 mm	8.54 mm	8.54 mm	8.54 mm	8.54 mm	8.54 mm
Cash burn (monthly)	3.27 mm	1.61 mm	2.97 mm	4.94 mm	3.27 mm	4.95 mm
Cash used (since last report)	52.49 mm	25.86 mm	47.63 mm	79.18 mm	52.41 mm	79.42 mm
Cash remaining	-43.96 mm	-17.33 mm	-39.10 mm	-70.65 mm	-43.87 mm	-70.88 mm
Runway (months of cash)	-13.4	-10.7	-13.2	-14.3	-13.4	-14.3

Beta Read what these cash burn values mean

Financial data from Aravive earnings reports.

Institutional ownership, Q3 2024

ARAV institutional ownership history Ownership history

72.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	6	6	–
Opened positions	0	1	EXIT
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	42.68 mm	42.68 mm	–
Total shares	53.18 mm	53.18 mm	–
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Eshelman Ventures	26.38 mm	$20.97 mm	0.0%
Eshelman Fredric N	10.07 mm	$18.93 mm	0.0%
Biotechnology Value Fund L P	8.16 mm	$327.00 k	0.0%
Artal International S.C.A.	7.61 mm	$0.00	0.0%
New Leaf Biopharma Opportunities II	946.42 k	$2.07 mm	0.0%
Massmutual Trust Co FSB	9.30 k	$373.00 k	0.0%

Largest transactions	Shares	Change
Biotechnology Value Fund L P	8.16 mm	0.0%
Eshelman Fredric N	10.07 mm	0.0%
Massmutual Trust Co FSB	9.30 k	0.0%
Artal International S.C.A.	7.61 mm	0.0%
Eshelman Ventures	26.38 mm	0.0%
New Leaf Biopharma Opportunities II	946.42 k	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.